Cargando…

Modulating P2X7 Receptor Signaling during Rheumatoid Arthritis: New Therapeutic Approaches for Bisphosphonates

P2X7 receptor-mediated purinergic signaling is a well-known mechanism involved in bone remodeling. The P2X7 receptor has been implicated in the pathophysiology of various bone and cartilage diseases, including rheumatoid arthritis (RA), a widespread and complex chronic inflammatory disorder. The P2X...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baroja-Mazo, Alberto, Pelegrín, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399340/ https://www.ncbi.nlm.nih.gov/pubmed/22830074 http://dx.doi.org/10.1155/2012/408242

Ejemplares similares

P2X7 Receptor Activation Impairs Exogenous MHC Class I Oligopeptides Presentation in Antigen Presenting Cells
por: Baroja-Mazo, Alberto, et al.
Publicado: (2013)

P2X7 receptor activation impairs antitumour activity of natural killer cells
por: Baroja‐Mazo, Alberto, et al.
Publicado: (2022)

Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity
por: García-Villalba, Julio, et al.
Publicado: (2022)

P2X7 Receptor Induces Tumor Necrosis Factor-α Converting Enzyme Activation and Release to Boost TNF-α Production
por: Barberà-Cremades, Maria, et al.
Publicado: (2017)

CD14 release induced by P2X7 receptor restricts inflammation and increases survival during sepsis
por: Alarcón-Vila, Cristina, et al.
Publicado: (2020)

Emerging Role of the Inflammasome and Pyroptosis in Hypertension
por: De Miguel, Carmen, et al.
Publicado: (2021)

The P2X(7) receptor–pannexin connection to dye uptake and IL-1β release
por: Pelegrin, Pablo, et al.
Publicado: (2009)

NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers
por: Hurtado-Navarro, Laura, et al.
Publicado: (2022)

Early endosome autoantigen 1 regulates IL-1β release upon caspase-1 activation independently of gasdermin D membrane permeabilization
por: Baroja-Mazo, Alberto, et al.
Publicado: (2019)

Author Correction: Early endosome autoantigen 1 regulates IL-1β release upon caspase-1 activation independently of gasdermin D membrane permeabilization
por: Baroja-Mazo, Alberto, et al.
Publicado: (2020)

P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis
por: Martínez-García, Juan José, et al.
Publicado: (2019)

Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy
por: Aeberli, Daniel, et al.
Publicado: (2013)

Emerging Role of NLRP3 Inflammasome and Pyroptosis in Liver Transplantation
por: Lucas-Ruiz, Fernando, et al.
Publicado: (2022)

Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process
por: de Torre-Minguela, Carlos, et al.
Publicado: (2016)

Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
por: Park, Ji-Heh, et al.
Publicado: (2017)

Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4
por: Pizzuto, Malvina, et al.
Publicado: (2019)

Lipin-2 regulates NLRP3 inflammasome by affecting P2X(7) receptor activation
por: Lordén, Gema, et al.
Publicado: (2017)

Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws
por: Conte-Neto, Nicolau, et al.
Publicado: (2012)

Involvement of P2X7 receptor in neuronal degeneration triggered by traumatic injury
por: Nadal-Nicolás, Francisco M., et al.
Publicado: (2016)

Extracellular ATP Activates the NLRP3 Inflammasome and Is an Early Danger Signal of Skin Allograft Rejection
por: Amores-Iniesta, Joaquín, et al.
Publicado: (2017)

P2X7 Receptors as a Therapeutic Target in Cerebrovascular Diseases
por: Cisneros-Mejorado, Abraham J., et al.
Publicado: (2020)

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
por: Dayer, Jean-Michel, et al.
Publicado: (2010)

Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritis
por: Churchman, Sarah M, et al.
Publicado: (2014)

Signalling and putative therapeutic molecules on the regulation of synoviocyte signalling in rheumatoid arthritis
por: Ji, Minjeong, et al.
Publicado: (2021)

P2X7 Receptor Signaling in Stress and Depression
por: Ribeiro, Deidiane Elisa, et al.
Publicado: (2019)

M1 and M2 Functional Imprinting of Primary Microglia: Role of P2X7 Activation and miR-125b
por: Parisi, Chiara, et al.
Publicado: (2016)

Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports
por: Conte-Neto, Nicolau, et al.
Publicado: (2011)

Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
por: Kaneko, Tetsuya, et al.
Publicado: (2019)

Chemokines in rheumatoid arthritis: novel, potential therapeutic targets of the CCR2 chemokine receptor signaling pathway
por: Matsushima, K, et al.
Publicado: (2003)

Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
por: Fukuda, Shin, et al.
Publicado: (2014)

Interleukin-7 deficiency in rheumatoid arthritis
por: Leonard, Warren J
Publicado: (2005)

The P2X7 receptor is a key modulator of aerobic glycolysis
por: Amoroso, F, et al.
Publicado: (2012)

Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis
por: Amadio, Susanna, et al.
Publicado: (2017)

SAT-532 Bisphosphonates Prevent Bone Loss Associated with Denosumab Treatment Discontinuation
por: Zanchetta, Maria Belen, et al.
Publicado: (2019)

Osteogenesis and osteoclast inhibition in rheumatoid arthritis patients treated with bisphosphonates alone or in combination with pitavastatin over an 18-month follow-up after more than 4 years of treatment with bisphosphonates
por: Nagashima, Masakazu, et al.
Publicado: (2012)

Bisphosphonate therapy and osteonecrosis of the jaw complicated with a temporal abscess in an elderly woman with rheumatoid arthritis: a case report
por: Manzon, Licia, et al.
Publicado: (2014)

Incidence and predictors of fragility fracture in postmenopausal rheumatoid arthritis patients receiving oral bisphosphonates: a longitudinal observational study
por: Kishimoto, Yuji, et al.
Publicado: (2022)

Future therapeutic targets in rheumatoid arthritis?
por: Cheung, Tommy Tsang, et al.
Publicado: (2017)

Therapeutic implications of autoantibodies in rheumatoid arthritis
por: Aletaha, Daniel, et al.
Publicado: (2016)

Therapeutic Cytokine Inhibition Modulates Activation and Homing Receptors of Peripheral Memory B Cell Subsets in Rheumatoid Arthritis Patients
por: Mahmood, Zafar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cnurrv3rcg2htt6en9ae2tvv1g